Stocksigma LogoStocksigma Logo

Neuland Laboratories Board to Consider Q2 and H1 FY27 Results on 3rd Nov'26

Neuland Laboratories Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider and approve the standalone and consolidated

Neuland Laboratories Board to Consider Q2 and H1 FY27 Results on 3rd Nov'26

Neuland Laboratories Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

Neuland Laboratories Board to Consider Q2 and H1 FY27 Results on 3rd Nov'26 Neuland Laboratories Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half year ended 30th Sep'26. Additionally, pursuant to the company's Insider Trading Code, the trading window for dealing in equity shares remains closed from 1st Oct'26 until 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Neuland Laboratories Ltd

All Neuland Laboratories Ltd announcements